|
ZNF167 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.195600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.959900E-03 |
| Normal-vs-Stage2 |
1.763780E-01 |
| Normal-vs-Stage3 |
4.893800E-02 |
| Normal-vs-Stage4 |
9.046400E-01 |
| Stage1-vs-Stage2 |
9.058600E-01 |
| Stage1-vs-Stage3 |
7.395700E-04 |
| Stage1-vs-Stage4 |
4.202000E-01 |
| Stage2-vs-Stage3 |
2.326500E-02 |
| Stage2-vs-Stage4 |
3.859000E-01 |
| Stage3-vs-Stage4 |
6.011600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.394200E-04 |
| Normal-vs-AfricanAmerican |
3.031400E-01 |
| Normal-vs-Asian |
9.422000E-01 |
| Caucasian-vs-AfricanAmerican |
1.543010E-01 |
| Caucasian-vs-Asian |
4.651200E-01 |
| AfricanAmerican-vs-Asian |
7.853800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.321600E-03 |
| Normal-vs-Female |
3.130300E-02 |
| Male-vs-Female |
7.582000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.294000E-01 |
| Normal-vs-Extreme_Weight |
8.375900E-02 |
| Normal-vs-Obese |
9.436400E-02 |
| Normal-vs-Extreme_Obese |
2.000000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.963200E-01 |
| Normal_Weight-vs-Obese |
7.362800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.382000E-01 |
| Extreme_Weight-vs-Obese |
9.021600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.935200E-01 |
| Obese-vs-Extreme_Obese |
7.519200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.851800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.216300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.414000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.539600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.777400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.388400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.823800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.397840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.761600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.133050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.1149999973602E-08 |
| Normal-VS-Type2 PRCC |
8.276300E-03 |
| Normal-VS-KIRP CIMP |
2.68673971959288E-14 |
| Normal-VS-Unclassified PRCC |
8.000800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.23465690396552E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.62447832963153E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
8.200400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.88530000394738E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
1.048080E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.3513000435571E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.107400E-01 |
| Normal-vs-N1 |
4.571200E-01 |
| Normal-vs-N2 |
5.169000E-04 |
| N0-vs-N1 |
4.079000E-01 |
| N0-vs-N2 |
3.558200E-02 |
| N1-vs-N2 |
2.543600E-02 |
|
|
